These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26516790)

  • 1. Understanding the structural mechanisms of antibiotic resistance sets the platform for new discovery.
    Reeve SM; Lombardo MN; Anderson AC
    Future Microbiol; 2015; 10(11):1727-33. PubMed ID: 26516790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blast from the Past: Reassessing Forgotten Translation Inhibitors, Antibiotic Selectivity, and Resistance Mechanisms to Aid Drug Development.
    Arenz S; Wilson DN
    Mol Cell; 2016 Jan; 61(1):3-14. PubMed ID: 26585390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecules that Inhibit Bacterial Resistance Enzymes.
    Liu Y; Li R; Xiao X; Wang Z
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30583527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial fatty acid metabolism in modern antibiotic discovery.
    Yao J; Rock CO
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Nov; 1862(11):1300-1309. PubMed ID: 27668701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
    Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analysis of the antibiotic resistome offers new opportunities for therapeutic intervention.
    Corona F; Blanco P; Alcalde-Rico M; Hernando-Amado S; Lira F; Bernardini A; Sánchez MB; Martínez JL
    Future Med Chem; 2016 Jun; 8(10):1133-51. PubMed ID: 27304087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of bacterial efflux pumps and computational approaches to study efflux pump inhibitors.
    Jamshidi S; Sutton JM; Rahman KM
    Future Med Chem; 2016; 8(2):195-210. PubMed ID: 26824720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postgenomic strategies in antibacterial drug discovery.
    Brötz-Oesterhelt H; Sass P
    Future Microbiol; 2010 Oct; 5(10):1553-79. PubMed ID: 21073314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keeping it simple: lessons from the golden era of antibiotic discovery.
    Lyddiard D; Jones GL; Greatrex BW
    FEMS Microbiol Lett; 2016 Apr; 363(8):. PubMed ID: 27036144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging structural information for the discovery of new drugs: computational methods.
    Nguyen TB; Wong SE; Lightstone FC
    Methods Mol Biol; 2012; 841():209-34. PubMed ID: 22222454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding efflux in Gram-negative bacteria: opportunities for drug discovery.
    Schweizer HP
    Expert Opin Drug Discov; 2012 Jul; 7(7):633-42. PubMed ID: 22607346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of efflux pumps as a novel approach to combat drug resistance in bacteria.
    Lomovskaya O; Watkins W
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):225-36. PubMed ID: 11321578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antibiotic resistance crisis, with a focus on the United States.
    Martens E; Demain AL
    J Antibiot (Tokyo); 2017 May; 70(5):520-526. PubMed ID: 28246379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic adjuvants - A strategy to unlock bacterial resistance to antibiotics.
    González-Bello C
    Bioorg Med Chem Lett; 2017 Sep; 27(18):4221-4228. PubMed ID: 28827113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review: Antibiotic discovery in the age of structural biology - a comprehensive overview with special reference to development of drugs for the treatment of Pseudomonas aeruginosa infection.
    Koehnke A; Friedrich RE
    In Vivo; 2015; 29(2):161-7. PubMed ID: 25792642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sources of novel antibiotics--aside the common roads.
    Donadio S; Maffioli S; Monciardini P; Sosio M; Jabes D
    Appl Microbiol Biotechnol; 2010 Dec; 88(6):1261-7. PubMed ID: 20865256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational analysis of bacterial cell wall peptides indicates how particular conformations have influenced the evolution of penicillin-binding proteins, beta-lactam antibiotics and antibiotic resistance mechanisms.
    Grail BM; Payne JW
    J Mol Recognit; 2002; 15(3):113-25. PubMed ID: 12203837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial drug discovery in the resistance era.
    Brown ED; Wright GD
    Nature; 2016 Jan; 529(7586):336-43. PubMed ID: 26791724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribosome-targeting antibiotics and mechanisms of bacterial resistance.
    Wilson DN
    Nat Rev Microbiol; 2014 Jan; 12(1):35-48. PubMed ID: 24336183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Variabilities in β-Lactamase (blaA) of Different Biovars of Yersinia enterocolitica: Implications for β-Lactam Antibiotic and β-Lactamase Inhibitor Susceptibilities.
    Singhal N; Srivastava A; Kumar M; Virdi JS
    PLoS One; 2014; 10(4):e0123564. PubMed ID: 25919756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.